Immunocore Holdings plc (IMCR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 40M 80M 120M Q3 '24: 80.2M Q4 '24: 84.1M Q1 '25: 93.9M Q2 '25: 98M Q3 '25: 103.7M Q4 '25: 104.5M Q1 '26: 106.7M Q2 '26: 115.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 40M 80M 120M Q3 '24: 79.8M Q4 '24: 83.7M Q1 '25: 93M Q2 '25: 96.9M Q3 '25: 103.2M Q4 '25: 101.8M Q1 '26: 106.2M Q2 '26: 114.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '24: -8.5M Q4 '24: -19.5M Q1 '25: -3.6M Q2 '25: -14.9M Q3 '25: -7.2M Q4 '25: -19.7M Q1 '26: 7.3M Q2 '26: -3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: 8.7M Q4 '24: -23.8M Q1 '25: 5M Q2 '25: -10.3M Q3 '25: -177K Q4 '25: -30.1M Q1 '26: 13M Q2 '26: -808K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 1M 2M 3M Q3 '24: 448K Q4 '24: 330K Q1 '25: 831K Q2 '25: 1M Q3 '25: 513K Q4 '25: 2.7M Q1 '26: 434K Q2 '26: 1.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-18M -9M 0 9M 18M 27M Q2 '24: 23.5M Q3 '24: 21.1M Q4 '24: -14M Q1 '25: 435K Q2 '25: 26M Q3 '25: -4.5M Q1 '26: -13.8M Q2 '26: 15.9M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-18M -9M 0 9M 18M 27M Q2 '24: 23.1M Q3 '24: 20.3M Q4 '24: -17.5M Q1 '25: 137K Q2 '25: 25.6M Q3 '25: -5.2M Q1 '26: -15.6M Q2 '26: 15.1M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 49.9M Q2 '24: 50M Q3 '24: 52.8M Q1 '25: 51.9M Q2 '25: 50.3M Q3 '25: 50.4M Q1 '26: 52.9M Q2 '26: 51M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q3 '24: -0.95 Q4 '24: -1.02 Q1 '25: -0.43 Q2 '25: -0.40 Q3 '25: -0.57 Q4 '25: -0.70 Q1 '26: -0.55 Q2 '26: -0.37 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.